216 related articles for article (PubMed ID: 25795131)
21. Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma.
Kim WY; Jeon YK; Kim TM; Kim JE; Kim YA; Lee SH; Kim DW; Heo DS; Kim CW
Ann Oncol; 2009 Oct; 20(10):1688-96. PubMed ID: 19542249
[TBL] [Abstract][Full Text] [Related]
22. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
[TBL] [Abstract][Full Text] [Related]
23. Regulatory T cells and their prognostic value in hepatopancreatobiliary tumours.
Ozgur HH; Ercetin AP; Eliyatkin N; Seren A; Kupelioglu A; Ortac R; Diniz G; Aktas S
Hepatogastroenterology; 2014 Oct; 61(135):1847-51. PubMed ID: 25713876
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells.
Fialová A; Partlová S; Sojka L; Hromádková H; Brtnický T; Fučíková J; Kocián P; Rob L; Bartůňková J; Spíšek R
Int J Cancer; 2013 Mar; 132(5):1070-9. PubMed ID: 22865582
[TBL] [Abstract][Full Text] [Related]
25. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma.
Sheu BC; Hsu SM; Ho HN; Lin RH; Torng PL; Huang SC
Cancer; 1999 Oct; 86(8):1537-43. PubMed ID: 10526283
[TBL] [Abstract][Full Text] [Related]
26. Adenocarcinoma contains more immune tolerance regulatory t-cell lymphocytes (versus squamous carcinoma) in non-small-cell lung cancer.
Black CC; Turk MJ; Dragnev K; Rigas JR
Lung; 2013 Jun; 191(3):265-70. PubMed ID: 23494387
[TBL] [Abstract][Full Text] [Related]
27. Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma.
de Vos van Steenwijk PJ; Ramwadhdoebe TH; Goedemans R; Doorduijn EM; van Ham JJ; Gorter A; van Hall T; Kuijjer ML; van Poelgeest MI; van der Burg SH; Jordanova ES
Int J Cancer; 2013 Dec; 133(12):2884-94. PubMed ID: 23740735
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor.
Chen WC; Lai YH; Chen HY; Guo HR; Su IJ; Chen HH
Histopathology; 2013 Aug; 63(2):225-33. PubMed ID: 23738752
[TBL] [Abstract][Full Text] [Related]
29. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.
Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES
Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737
[TBL] [Abstract][Full Text] [Related]
30. Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus.
Zingg U; Montani M; Frey DM; Dirnhofer S; Esterman AJ; Went P; Oertli D
Eur J Surg Oncol; 2010 Jul; 36(7):670-7. PubMed ID: 20510571
[TBL] [Abstract][Full Text] [Related]
31. Forkhead box P3-positive regulatory T-cells and interleukin 17-positive T-helper 17 cells in chronic inflammatory periodontal disease.
Parachuru VP; Coates DE; Milne TJ; Hussaini HM; Rich AM; Seymour GJ
J Periodontal Res; 2014 Dec; 49(6):817-26. PubMed ID: 24506561
[TBL] [Abstract][Full Text] [Related]
32. Increased prevalence of interleukin-17-producing CD4(+) tumor infiltrating lymphocytes in human oral squamous cell carcinoma.
Lee JJ; Chang YL; Lai WL; Ko JY; Kuo MY; Chiang CP; Azuma M; Chen CW; Chia JS
Head Neck; 2011 Sep; 33(9):1301-8. PubMed ID: 21837700
[TBL] [Abstract][Full Text] [Related]
33. Tumor-infiltrating lymphocytes contain a higher proportion of FOXP3(+) T lymphocytes in cervical cancer.
Wu MY; Kuo TY; Ho HN
J Formos Med Assoc; 2011 Sep; 110(9):580-6. PubMed ID: 21930068
[TBL] [Abstract][Full Text] [Related]
34. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
[TBL] [Abstract][Full Text] [Related]
35. Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses.
Santegoets SJ; Duurland CL; Jordanova ES; van Ham JJ; Ehsan I; van Egmond SL; Welters MJP; van der Burg SH
J Immunother Cancer; 2019 Jan; 7(1):14. PubMed ID: 30658697
[TBL] [Abstract][Full Text] [Related]
36. Peritumoral FOXP3⁺ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3⁺ regulatory T cell is prognostic predictor of breast cancer patients.
Liu F; Li Y; Ren M; Zhang X; Guo X; Lang R; Gu F; Fu L
Breast Cancer Res Treat; 2012 Sep; 135(2):459-67. PubMed ID: 22842982
[TBL] [Abstract][Full Text] [Related]
37. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
[TBL] [Abstract][Full Text] [Related]
38. Distribution of Th17 cells and Foxp3-expressing T cells in tumor-infiltrating lymphocytes in patients with uterine cervical cancer.
Hou F; Li Z; Ma D; Zhang W; Zhang Y; Zhang T; Kong B; Cui B
Clin Chim Acta; 2012 Nov; 413(23-24):1848-54. PubMed ID: 22820395
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E
Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488
[TBL] [Abstract][Full Text] [Related]
40. Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6.
Guo D; Chen Y; Wang S; Yu L; Shen Y; Zhong H; Yang Y
Immunology; 2018 May; 154(1):132-143. PubMed ID: 29197065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
